JGJianhang Gong

Jianhang Gong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jianhang Gong has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Feng Lu

    Department of Epidemiology and Biostatistics, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China

    1 shared publication
  • Guangfu Jin

    State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China

    1 shared publication
  • Hongbing Shen

    Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; State Key Laboratory Cultivation Base of Biomarkers for Cancer Precision Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China

    1 shared publication
  • Huizhang Li

    Department of Epidemiology and Biostatistics, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China

    1 shared publication
  • Jiangbo Du

    Department of Epidemiology and Biostatistics, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China

    1 shared publication
  • Juncheng Dai

    Nanjing Medical University

    1 shared publication

Latest Publications

  • Open Access

    Genetic variant in fat mass and obesity-associated gene associated with type 2 diabetes risk in Han Chinese

    by Yun Qian, Sijun Liu, Feng Lu, Huizhang Li, Meihua Dong, Yudi Lin, Jiangbo Du, Yuan Lin, Jianhang Gong, Guangfu Jin, et al.

    Genome-wide association study (GWAS) has identified that rs8050136 C/A polymorphism in fat mass and obesity-associated gene (FTO) was associated with the risk of type 2 diabetes (T2D) in Europeans. But this association was abolished after adjustment for body mass index (BMI), suggesting that the effect of rs8050136 on T2D risk might be mediated by BMI in Europeans. However, the findings in subsequent studies were inconsistent among Asian populations. To determine whether rs8050136 polymorphism in FTO is independently associated with the risk of T2D in Chinese, we conducted a case–control study with 2,925 T2D patients and 3,281 controls in Han Chinese. Logistic regression revealed that the A allele of rs8050136 was significantly associated with an increased risk of T2D, independent of BMI (odds ratio (OR) = 1.17, 95% confidence interval (95% CI) = 1.03-1.32, p = 0.016). Meta-analysis containing 10 reported studies and our data with a total of 15,819 cases and 18,314 controls further confirmed the association between rs8050136 polymorphism and T2D risk in East Asians (OR = 1.13, 95% CI = 1.07-1.19). Our findings indicate that the genetic variant in FTO may contribute to T2D risk in Han Chinese and rs8050136 polymorphism may be a genetic marker for T2D susceptibility.